Your browser doesn't support javascript.
loading
Proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations.
Lim, Su Lin; Damnernsawad, Alisa; Shyamsunder, Pavithra; Chng, Wee Joo; Han, Bing Chen; Xu, Liang; Pan, Jian; Pravin, Dakle Pushkar; Alkan, Serhan; Tyner, Jeffrey W; Koeffler, H Phillip.
Afiliação
  • Lim SL; Cedars Sinai Medical Center, Los Angeles, CA, USA sulin_lim_86@hotmail.com.
  • Damnernsawad A; Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA.
  • Shyamsunder P; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Chng WJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Han BC; Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Xu L; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Pan J; Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Pravin DP; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Alkan S; Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Tyner JW; Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA.
  • Koeffler HP; Cedars Sinai Medical Center, Los Angeles, CA, USA.
Haematologica ; 104(6): 1209-1220, 2019 06.
Article em En | MEDLINE | ID: mdl-30606790
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Terapia de Alvo Molecular / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Haematologica Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Terapia de Alvo Molecular / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Haematologica Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos